Form D — Inomagen Therapeutics, Inc.
0001626370-25-000002 · filed 2025-06-20
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- $3,778,984
- Total sold
- $140,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Inomagen Therapeutics, Inc.
- CIK
- 1626370
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1375 W Fulton Street
CHICAGO, IL 60607 - Phone
- 312 805 8701
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Rishi Arora · Executive OfficerChicago, IL Find on LinkedIn ↗
-
James R. Vogler · DirectorChicago, IL Find on LinkedIn ↗
-
Marc Penn · DirectorChicago, IL Find on LinkedIn ↗
View original on SEC EDGAR.